Zhanxiang Zhang

Harbin Institute of Technology

Papers

1

Total Citations

10

H-Index

1

About

Dr. Zhanxiang Zhang is a pioneering researcher at the intersection of biomedical engineering and oncology, whose work focuses on developing advanced micro-robotic drug delivery systems for targeted cancer therapy. His most impactful contribution is the design of magnetic-driven hydrogel microrobots, which represent a paradigm shift from passive, circulation-dependent drug delivery to active, navigable therapeutic platforms. In his landmark 2024 study, Zhang demonstrated how these microrobots can be precisely guided to osteosarcoma tumors, enabling a synthetic lethality strategy that synergistically enhances chemotherapy efficacy while minimizing systemic toxicity. This work, already garnering 10 citations shortly after publication, has been recognized for its innovative integration of soft robotics, magnetic actuation, and nanomedicine. Zhang’s research addresses a critical bottleneck in oncology—the need for spatially controlled drug release—and his findings have implications for treating other solid tumors. By engineering microrobots that can autonomously navigate complex biological environments, he is laying the groundwork for next-generation, minimally invasive cancer treatments that promise to improve patient outcomes and reduce side effects.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Magnetic-driven hydrogel microrobots for promoting osteosarcoma chemo-therapy with synthetic lethality strategy
10 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Harbin Institute of Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago